drugset / Trial / NCT00069186

Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis

NCT00069186

Phase 3 Unknown 107 enrolled The Avicena Group
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether nine months of administration of creatine monohydrate results in an increase in muscle strength in patients with amyotrophic lateral sclerosis (ALS).

Timeline

Start
2003-06
Primary completion
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Creatine Other / unclassified 5 g